Scientists say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals‘ lifespan.
Quelle: ScienceDaily | Immune System
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors
- Scientists discover that special immune cells stop metastatic cancer
- Preventing organ transplant rejection
- Role of gamma-delta T cells in cancer immunology
- New study finds a promising combined therapy for multiple sclerosis
- Researchers discovered mechanism driving immune perturbations after severe infections
- New mouse models offer valuable window into COVID-19 infection
- Promising TB therapy appears safe for patients with HIV
- Could a bout of COVID protect you from a severe case of flu?
- Immunotherapy for gum disease? Study in mice shows promise
